In our present study, we have also confirmed the expression pattern of KRT19 in MDA-MB231 and highly aggressive and drug-resistant breast cancer patient-derived cancer stem cell-like KU-CSLC (konkuk University-cancer stem cell-like cell) cells, using RT-PCR and western blot (WB) analysis (Figure 2A). This evidence concerns the gene KRT19 and breast cancer.